Literature DB >> 2587833

Observations on sputum production in patients with variable airflow obstruction; implications for the diagnosis of asthma and chronic bronchitis.

P J Openshaw1, M Turner-Warwick.   

Abstract

There are few clinical studies on hypersecretion in asthma, defined as variable airflow obstruction. One hundred and thirty defined asthmatics were questioned in detail about their clinical features, with special reference to sputum production. Other clinical and laboratory data were obtained from the hospital notes. Thirty (23%) denied sputum production at any time. Of the hundred patients reporting sputum, 55 reported the largest volume when an attack of asthma was at its worst and 42 reported most sputum during recovery. Three patients reported unchanging sputum volumes regardless of asthma attacks. There was an association between greater sputum volumes and increased absenteeism due to respiratory symptoms (P less than 0.01) and negative prick skin tests (P less than 0.001). Cigarette smoking and bronchopulmonary aspergillosis were uncommon among our patients, and did not alone account for the sputum production rates. Sixty-eight per cent of patients reported that their pattern or volume of sputum production during attacks had not changed substantially since the onset of their asthma. Patients also fulfilling the Medical Research Council (MRC) criteria for chronic bronchitis (n = 56) were more likely to have smoked than those who did not (P less than 0.005), although 32 (57%) of the asthmatics with chronic bronchitis had smoked little or not at all. Moreover the lability of peak flow measurements was similar in asthmatic patients with and without chronic bronchitis (Lability index 43 and 42% respectively). The prevalence of persistent airflow limitation (PAL) in addition to a variable component related to duration of asthma but not to smoking. The relation between PAL and sputum production was complex.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2587833     DOI: 10.1016/s0954-6111(89)80056-3

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure.

Authors:  E F Christensen; R Dahl
Journal:  Lung       Date:  1991       Impact factor: 2.584

2.  The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.

Authors:  James P Allinson; Rebecca Hardy; Gavin C Donaldson; Seif O Shaheen; Diana Kuh; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2016-03-15       Impact factor: 21.405

Review 3.  Mucin gene expression in rhinitis syndromes.

Authors:  Asunción Martínez-Antón; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2006-05       Impact factor: 4.919

4.  Titanium dioxide particle-induced goblet cell hyperplasia: association with mast cells and IL-13.

Authors:  Mi-Hyun Ahn; Chun-Mi Kang; Choon-Sik Park; Sang-Jun Park; Taiyoun Rhim; Pyeong-Oh Yoon; Hun Soo Chang; Soo-Ho Kim; Hiroko Kyono; Kwang Chul Kim
Journal:  Respir Res       Date:  2005-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.